Jin Medical International... (ZJYL)
Jin Medical International Ltd. Statistics
Share Statistics
Jin Medical International Ltd. has 156.55M shares outstanding. The number of shares has increased by 0% in one year.
Shares Outstanding | 156.55M |
Shares Change (YoY) | 0% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 37.82M |
Failed to Deliver (FTD) Shares | 1.48K |
FTD / Avg. Volume | 0.46% |
Short Selling Information
The latest short interest is 1.34M, so 0.85% of the outstanding shares have been sold short.
Short Interest | 1.34M |
Short % of Shares Out | 0.85% |
Short % of Float | 3.53% |
Short Ratio (days to cover) | 2.75 |
Valuation Ratios
The PE ratio is 114.51 and the forward PE ratio is null. Jin Medical International Ltd.'s PEG ratio is 6.13.
PE Ratio | 114.51 |
Forward PE | n/a |
PS Ratio | 17.91 |
Forward PS | null |
PB Ratio | 14.61 |
P/FCF Ratio | -180.53 |
PEG Ratio | 6.13 |
Enterprise Valuation
Jin Medical International Ltd. has an Enterprise Value (EV) of 166.99M.
EV / Earnings | 45.43 |
EV / Sales | 7.11 |
EV / EBITDA | 41.91 |
EV / EBIT | 45.89 |
EV / FCF | -71.62 |
Financial Position
The company has a current ratio of 2.5, with a Debt / Equity ratio of 0.4.
Current Ratio | 2.5 |
Quick Ratio | 2.19 |
Debt / Equity | 0.4 |
Total Debt / Capitalization | 28.71 |
Cash Flow / Debt | -0.1 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.13% and return on capital (ROIC) is 7.41%.
Return on Equity (ROE) | 0.13% |
Return on Assets (ROA) | 0.08% |
Return on Capital (ROIC) | 7.41% |
Revenue Per Employee | $87,368.07 |
Profits Per Employee | $13,665.16 |
Employee Count | 269 |
Asset Turnover | 0.51 |
Inventory Turnover | 2.71 |
Taxes
Income Tax | 763.88K |
Effective Tax Rate | 0.18 |
Stock Price Statistics
The stock price has increased by -81.25% in the last 52 weeks. The beta is 1.92, so Jin Medical International Ltd.'s price volatility has been higher than the market average.
Beta | 1.92 |
52-Week Price Change | -81.25% |
50-Day Moving Average | 0.82 |
200-Day Moving Average | 1.89 |
Relative Strength Index (RSI) | 42.92 |
Average Volume (20 Days) | 320.44K |
Income Statement
In the last 12 months, Jin Medical International Ltd. had revenue of 23.5M and earned 3.68M in profits. Earnings per share was 0.02.
Revenue | 23.5M |
Gross Profit | 9.5M |
Operating Income | 3.64M |
Net Income | 3.68M |
EBITDA | 3.98M |
EBIT | 3.64M |
Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 8.14M in cash and 11.6M in debt, giving a net cash position of -3.47M.
Cash & Cash Equivalents | 8.14M |
Total Debt | 11.6M |
Net Cash | -3.47M |
Retained Earnings | 20.02M |
Total Assets | 45.8M |
Working Capital | 25.66M |
Cash Flow
In the last 12 months, operating cash flow was -1.21M and capital expenditures -1.12M, giving a free cash flow of -2.33M.
Operating Cash Flow | -1.21M |
Capital Expenditures | -1.12M |
Free Cash Flow | -2.33M |
FCF Per Share | -0.01 |
Margins
Gross margin is 40.43%, with operating and profit margins of 15.48% and 15.64%.
Gross Margin | 40.43% |
Operating Margin | 15.48% |
Pretax Margin | 17.8% |
Profit Margin | 15.64% |
EBITDA Margin | 16.96% |
EBIT Margin | 15.48% |
FCF Margin | -9.92% |
Dividends & Yields
ZJYL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 2.78% |
FCF Yield | -2.07% |
Analyst Forecast
Currently there are no analyst rating for ZJYL.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Feb 8, 2024. It was a forward split with a ratio of 20:1.
Last Split Date | Feb 8, 2024 |
Split Type | forward |
Split Ratio | 20:1 |
Scores
Altman Z-Score | 5.93 |
Piotroski F-Score | 3 |